Human normal immunoglobulin (HNIG) is another name for immune globulin or immunoglobulin. It is a substance obtained from the blood of human donors. Human normal immunoglobulin is marketed under a variety of brand names. It is available for intramuscular injection (IGIM), subcutaneous injection (SCIG) and, more commonly, intravenous injection (IVIG or IGIV). It contains general antibodies that are not specific to a particular infection. It is administered to people with weakened immune systems caused by primary immunodeficiency (PI), idiopathic thrombocytopenic purpura (ITP) and chronic inflammatory demyelinating polyneuropathy (CIDP). It is not intended for use in patients with acquired immune deficiencies.
- Q How does human normal immunoglobulin treat ITP?
- Q Who should take human normal immunoglobulin?
- Q Who should not take human normal immunoglobulin?
- Q What happens if I miss a dose of human normal immunoglobulin?
- Q What is the typical dosage for human normal immunoglobulin?
- Q Are there any risks associated with receiving human normal immunoglobulin?